Lars Bullinger

About Lars Bullinger

Lars Bullinger, With an exceptional h-index of 92 and a recent h-index of 67 (since 2020), a distinguished researcher at Charité - Universitätsmedizin Berlin, specializes in the field of Hematology, Oncology, Tumorimmunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Association of an impaired GH-IGF-I axis with cardiac wasting in patients with advanced cancer

Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry

HLA-C* 04: 09N is expressed at the cell surface and triggers peptide-specific T-cell activation

Long read sequencing allows comprehensive molecular profiling of complex karyotype acute myeloid leukemia (CKAML) with 5q deletions

Oligonucleotide library screening for identification of virus‐specific T‐cell receptors

Comparable CD8+ T‐cell responses to SARS‐CoV‐2 vaccination in single‐cell transcriptomics of recently allogeneic transplanted patients and healthy individuals

Covering Hierarchical Dirichlet Mixture Models on binary data to enhance genomic stratifications in onco-hematology

Genetic characterization of primary mediastinal B-cell lymphoma: pathogenesis and patient outcomes

Lars Bullinger Information

University

Position

___

Citations(all)

42634

Citations(since 2020)

20244

Cited By

30902

hIndex(all)

92

hIndex(since 2020)

67

i10Index(all)

268

i10Index(since 2020)

231

Email

University Profile Page

Google Scholar

Lars Bullinger Skills & Research Interests

Hematology

Oncology

Tumorimmunology

Top articles of Lars Bullinger

Association of an impaired GH-IGF-I axis with cardiac wasting in patients with advanced cancer

Clinical Research in Cardiology

2024/4/8

Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry

Blood Journal

2024/1/26

Lars Bullinger
Lars Bullinger

H-Index: 62

Julian Strobel
Julian Strobel

H-Index: 9

HLA-C* 04: 09N is expressed at the cell surface and triggers peptide-specific T-cell activation

Haematologica

2024/4/4

Lars Bullinger
Lars Bullinger

H-Index: 62

Julian Strobel
Julian Strobel

H-Index: 9

Long read sequencing allows comprehensive molecular profiling of complex karyotype acute myeloid leukemia (CKAML) with 5q deletions

Cancer Research

2024/3/22

Frederik Damm
Frederik Damm

H-Index: 25

Lars Bullinger
Lars Bullinger

H-Index: 62

Oligonucleotide library screening for identification of virus‐specific T‐cell receptors

European Journal of Immunology

2024/3/19

Lars Bullinger
Lars Bullinger

H-Index: 62

Comparable CD8+ T‐cell responses to SARS‐CoV‐2 vaccination in single‐cell transcriptomics of recently allogeneic transplanted patients and healthy individuals

Journal of medical virology

2024/3

Andreas Thiel
Andreas Thiel

H-Index: 12

Lars Bullinger
Lars Bullinger

H-Index: 62

Covering Hierarchical Dirichlet Mixture Models on binary data to enhance genomic stratifications in onco-hematology

PLOS Computational Biology

2024/2/2

Genetic characterization of primary mediastinal B-cell lymphoma: pathogenesis and patient outcomes

Journal of Clinical Oncology

2024/2/1

Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemia

Nature Cancer

2024/1

Lars Bullinger
Lars Bullinger

H-Index: 62

Thrombus or tumor? A case report of a rare sarcoma entity: intimal sarcoma of the pulmonary arteries

Molecular Biology Reports

2024/12

Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer

Leukemia

2024/4/18

Making AML fly too close to the sun

Blood

2024/4/11

Lars Bullinger
Lars Bullinger

H-Index: 62

Jan Krönke
Jan Krönke

H-Index: 18

Associations of clonal hematopoiesis with recurrent vascular events and death in patients with incident ischemic stroke

Blood

2023/2/16

Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion

Science Advances

2023/9/22

Olaf Penack
Olaf Penack

H-Index: 28

Lars Bullinger
Lars Bullinger

H-Index: 62

Inferior outcomes of EU versus US patients treated with CD19 CAR-T for relapsed/refractory large B-cell lymphoma: association with differences in tumor burden, systemic …

Hemasphere

2023/8/1

The Genomic Landscape and Its Clinical Implication in NPM1-Mutated AML Patients: A Study within the AMLSG 09-09 Clinical Trial

Blood

2023/11/28

Isabelle Schneider
Isabelle Schneider

H-Index: 7

Lars Bullinger
Lars Bullinger

H-Index: 62

Long-Term Outcome of 1296 Patients with Newly Diagnosed with APL: A Harmony Alliance Study

Blood

2023/11/28

Response to anti‐SARS‐CoV‐2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients

International Journal of Cancer

2023/2/15

Joanna Zaleska
Joanna Zaleska

H-Index: 2

Lars Bullinger
Lars Bullinger

H-Index: 62

Hand grip strength in patients with advanced cancer: A prospective study

Journal of Cachexia, Sarcopenia and Muscle

2023/8

Ulrich Keller
Ulrich Keller

H-Index: 14

Lars Bullinger
Lars Bullinger

H-Index: 62

Clonal Hematopoiesis in Whole-Blood and Cell-Free DNA of Ovarian Cancer Patients Undergoing PARP-Inhibitor Treatment: An Exploratory Analysis of the ENGOT-ov48/Eudario Trial

Blood

2023/11/28

See List of Professors in Lars Bullinger University(Charité - Universitätsmedizin Berlin)